Skip to content

Clinical trials

Completed Hepatitis B trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Status: Completed Country / region: South Korea Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20104
20111
20124
20142
20154
20161
20173
20186
20204
20216
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Vir Biotechnology, Inc.5
Dong-A ST Co., Ltd.3
Gilead Sciences3
Bristol-Myers Squibb2
Bukwang Pharmaceutical2
Green Cross Corporation2
LG Chem2
Sanofi Pasteur, a Sanofi Company2
Alios Biopharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B43
Hepatitis B, Chronic18
Hepatitis13
Hepatitis, Chronic4
Diphtheria3
Haemophilus Infections3
Poliomyelitis3
Tetanus3
Whooping Cough3
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.